• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Inomax (nitric oxide) for Inhalation

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- August 2009


Summary View



Heart Failure
  • In patients with pre-existing left ventricular dysfunction, inhaled nitric oxide may increase pulmonary capillary wedge pressure leading to pulmonary edema.
  • Patients who had pre-existing left ventricular dysfunction treated with inhaled nitric oxide, even for
    short durations, experienced serious adverse events (e.g., pulmonary edema).